Study on Effective Factors of Secondary Prevention in Ischemic Stroke Recurrence

Background and Aim: Recurrent ischemic stroke is a major contributor to long-term disability and healthcare burden. Identifying clinical and modifiable factors associated with recurrence is essential for improving secondary prevention. This study aimed to investigate factors associated with recurrent ischemic stroke, with particular emphasis on vascular risk factors, stroke severity, rehabilitation, lifestyle modification, and adherence to preventive pharmacotherapy. Methods In this retrospective case-control study, 194 patients admitted with ischemic stroke to Imam Reza Training Hospital, Tabriz, Iran, between 2016 and 2023 were evaluated. The study included 97 patients with recurrent ischemic stroke. Demographic characteristics, vascular risk factors, National Institutes of Health Stroke Scale (NIHSS), modified Rankin Scale (mRS), rehabilitation utilization, lifestyle factors, and use of secondary prevention medications were assessed. Between-group and within-patient comparisons were performed using appropriate parametric and non-parametric statistical tests. Results A history of hypertension was more common among patients with recurrent stroke than controls (83.5% vs. 60.8%, p < 0.001). Patients who subsequently experienced recurrent stroke had lower NIHSS scores at initial admission (median 8 vs. 10, p = 0.057) and at discharge (median 5 vs. 9, p = 0.003) than controls. Among patients with recurrent stroke, stroke severity increased at the time of recurrence, with median NIHSS increasing from 8 to 10 (p = 0.019). During the interval between the first and recurrent stroke, use of anticoagulants decreased from 28.6% to 17.5% (p < 0.001), lipid-lowering therapy from 70.1% to 49.5% (p = 0.001), and antiplatelet therapy from 72.2% to 48.4% (p < 0.001). At recurrence, fasting blood glucose increased from 109 to 117 mg/dL (p < 0.001), while HDL cholesterol decreased from 36 to 33 mg/dL (p = 0.002). Conclusion Recurrent ischemic stroke was associated with hypertension, a history of previous cerebrovascular events, reduced use of secondary prevention medications, lower utilization of inpatient rehabilitation, and adverse metabolic changes. Although patients who subsequently experienced recurrence initially had less severe strokes than controls, neurological severity increased at the recurrent event. These findings highlight the importance of sustained pharmacological treatment, vascular risk-factor control, and rehabilitation as components of secondary stroke prevention. Prospective multicenter studies are warranted to determine the extent to which improving adherence and risk-factor management can reduce recurrence.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-20
DOI
https://doi.org/10.21203/rs.3.rs-11497294/v1
Primary Topic
Acute Ischemic Stroke Management
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Study on Effective Factors of Secondary Prevention in Ischemic Stroke Recurrence

Mehdi Farhoudi, Robab Mehdizadeh Esfanjani, Hadi Sahrai, Roya Rostami et al.
Research Square
Acute Ischemic Stroke Management
preprint

Study on Effective Factors of Secondary Prevention in Ischemic Stroke Recurrence

Mehdi Farhoudi, Robab Mehdizadeh Esfanjani, Hadi Sahrai, Roya Rostami, Vida Mamdouhi, Mazyar Hashemilar
preprint en

Abstract

Background and Aim: Recurrent ischemic stroke is a major contributor to long-term disability and healthcare burden. Identifying clinical and modifiable factors associated with recurrence is essential for improving secondary prevention. This study aimed to investigate factors associated with recurrent ischemic stroke, with particular emphasis on vascular risk factors, stroke severity, rehabilitation, lifestyle modification, and adherence to preventive pharmacotherapy. Methods In this retrospective case-control study, 194 patients admitted with ischemic stroke to Imam Reza Training Hospital, Tabriz, Iran, between 2016 and 2023 were evaluated. The study included 97 patients with recurrent ischemic stroke. Demographic characteristics, vascular risk factors, National Institutes of Health Stroke Scale (NIHSS), modified Rankin Scale (mRS), rehabilitation utilization, lifestyle factors, and use of secondary prevention medications were assessed. Between-group and within-patient comparisons were performed using appropriate parametric and non-parametric statistical tests. Results A history of hypertension was more common among patients with recurrent stroke than controls (83.5% vs. 60.8%, p < 0.001). Patients who subsequently experienced recurrent stroke had lower NIHSS scores at initial admission (median 8 vs. 10, p = 0.057) and at discharge (median 5 vs. 9, p = 0.003) than controls. Among patients with recurrent stroke, stroke severity increased at the time of recurrence, with median NIHSS increasing from 8 to 10 (p = 0.019). During the interval between the first and recurrent stroke, use of anticoagulants decreased from 28.6% to 17.5% (p < 0.001), lipid-lowering therapy from 70.1% to 49.5% (p = 0.001), and antiplatelet therapy from 72.2% to 48.4% (p < 0.001). At recurrence, fasting blood glucose increased from 109 to 117 mg/dL (p < 0.001), while HDL cholesterol decreased from 36 to 33 mg/dL (p = 0.002). Conclusion Recurrent ischemic stroke was associated with hypertension, a history of previous cerebrovascular events, reduced use of secondary prevention medications, lower utilization of inpatient rehabilitation, and adverse metabolic changes. Although patients who subsequently experienced recurrence initially had less severe strokes than controls, neurological severity increased at the recurrent event. These findings highlight the importance of sustained pharmacological treatment, vascular risk-factor control, and rehabilitation as components of secondary stroke prevention. Prospective multicenter studies are warranted to determine the extent to which improving adherence and risk-factor management can reduce recurrence.

Research Square
Tabriz University of Medical Sciences (IR)
Acute Ischemic Stroke Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon